A detailed history of Sarissa Consulting LLC transactions in Covetrus, Inc. stock. As of the latest transaction made, Sarissa Consulting LLC holds 31,651 shares of CVET stock, worth $0. This represents 0.68% of its overall portfolio holdings.

Number of Shares
31,651
Holding current value
$0
% of portfolio
0.68%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$20.69 - $20.91 $654,859 - $661,822
31,651 New
31,651 $661,000

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Sarissa Consulting LLC Portfolio

Follow Sarissa Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Consulting LLC with notifications on news.